Lipoprotein(a) and long-term revascularization burden: a recurrent-event analysis of the UK Biobank

Clicks: 9
ID: 332391
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #250 of 272 articles by views in european journal of preventive cardiology

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 272 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Aims To investigate whether elevated Lp(a) is independently associated with cumulative coronary, peripheral, and carotid revascularization burden in a primary prevention cohort. Methods and results We analysed 237 729 UK Biobank participants of European ancestry free of ASCVD at baseline, followed for a median of 14.1 years. Lp(a) was analysed using the ESC/EAS 2025 threshold of 105 nmol/L and continuously (per 50 nmol/L increment). The primary outcome was the total number of coronary, peripheral, and carotid revascularization procedures per person. Given the genetically determined, lifelong nature of Lp(a) exposure, to capture the full sequence of procedures over time, rather than time-to-first-event alone, we applied recurrent-event statistical models, including the Andersen–Gill model, negative binomial regression, and the Prentice–Williams–Peterson gap–time model. Overall, 10 731 revascularization procedures occurred in 237 729 participants. The proportion undergoing ≥1 procedure was higher with Lp(a) ≥ 105 vs. <105 nmol/L (4.36% vs. 2.96%), with larger differences for ≥2 (1.53% vs. 0.95%) and ≥3 procedures (0.36% vs. 0.18%). In Andersen–Gill analysis, Lp(a) ≥ 105 nmol/L was associated with a higher revascularization rate (HR 1.50, 1.42–1.60), with a 55% higher rate of revascularization procedures during follow-up by negative binomial regression (IRR 1.55, 1.45–1.65). The association was strongest for the first procedure (HR 1.48, 1.40–1.56), attenuated for the second (HR 1.28, 1.09–1.50), and non-significant for the third (HR 1.23, 0.94–1.62). Findings were consistent across coronary and peripheral territories. Conclusion In this large primary prevention cohort, elevated Lp(a) was independently associated with a higher long-term revascularization burden across multiple vascular territories. The association was robust for coronary, supportive for peripheral, and inconclusive for carotid revascularization owing to limited statistical power. These findings, derived from recurrent-event methodology, provide a more complete quantification of Lp(a)-associated cardiovascular procedural risk than time-to-first-event analyses alone.
Reference Key
openalex_W7221813503 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Arturo Cesaro, Paolo Calabrò, Oveis Jamialahmadi, Nicola Pugliese, Valentina Flagiello, Emelie Barreby, Rosellina Margherita Mancina, Stefano Romeo
Journal european journal of preventive cardiology
Year 2026
DOI
10.1093/eurjpc/zwag499
URL
https://doi.org/10.1093/eurjpc/zwag499
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.